| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 437.37B | 396.67B | 403.50B | 365.69B | 312.66B |
| Gross Profit | 177.54B | 161.21B | 164.66B | 149.44B | 123.91B |
| EBITDA | 66.21B | 67.01B | 74.44B | 67.19B | 56.82B |
| Net Income | 30.55B | 32.39B | 40.64B | 34.16B | 27.77B |
Balance Sheet | |||||
| Total Assets | 772.11B | 649.89B | 681.05B | 647.56B | 614.44B |
| Cash, Cash Equivalents and Short-Term Investments | 153.63B | 132.03B | 126.41B | 123.28B | 130.17B |
| Total Debt | 80.80B | 21.51B | 18.88B | 15.01B | 14.02B |
| Total Liabilities | 231.75B | 126.14B | 146.66B | 139.04B | 130.40B |
| Stockholders Equity | 535.47B | 519.21B | 529.66B | 504.13B | 479.79B |
Cash Flow | |||||
| Free Cash Flow | 52.49B | 39.41B | 36.57B | 4.50B | 44.71B |
| Operating Cash Flow | 58.06B | 46.19B | 47.59B | 24.95B | 56.87B |
| Investing Cash Flow | -25.17B | 7.85B | -15.19B | -13.32B | -7.92B |
| Financing Cash Flow | 13.74B | -42.42B | -38.15B | -20.39B | -22.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥485.91B | 19.34 | 14.28% | 2.40% | 8.33% | 27.80% | |
74 Outperform | ¥894.28B | 30.94 | 5.14% | 3.31% | 10.26% | -2.44% | |
73 Outperform | ¥56.55B | 14.37 | ― | 2.54% | 3.47% | -12.26% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥648.41B | 20.29 | 4.83% | 2.95% | 2.18% | 5504.89% | |
60 Neutral | ¥368.33B | 26.70 | ― | 1.65% | 5.02% | 19.84% | |
49 Neutral | ¥577.63B | 29.34 | 11.66% | 1.03% | 10.58% | 7.11% |